Literature DB >> 12204778

Oral contraception and epilepsy: findings in a large cohort study.

Martin Vessey1, Rosemary Painter, David Yeates.   

Abstract

There is no good evidence that oral contraceptives (OCs) increase the risk of epilepsy in unaffected women or increase the frequency of seizures in those suffering from the disorder. Nonetheless, manufacturers' literature continues to include warnings about OCs and epilepsy. We have analyzed the available data about epilepsy in the Oxford-Family Planning Association contraceptive study that includes 17,032 women followed for periods of up to 26 years. In total, 82 women (with no record of having suffered epilepsy when recruited to the study) were referred to hospital for diagnosis or treatment of epilepsy during the follow-up period. No association was found between OC use and the occurrence of the condition. Referral to hospital was, however, more frequent in women of low social class and in those with a high body mass index.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204778     DOI: 10.1016/s0010-7824(02)00323-2

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

1.  Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives.

Authors:  Doodipala Samba Reddy
Journal:  Expert Rev Clin Pharmacol       Date:  2010-03-01       Impact factor: 5.045

2.  Female reproductive factors and risk of seizure or epilepsy: data from the Nurses' Health Study II.

Authors:  Barbara A Dworetzky; Mary K Townsend; Page B Pennell; Jae H Kang
Journal:  Epilepsia       Date:  2011-11-02       Impact factor: 5.864

3.  Do oral contraceptives increase epileptic seizures?

Authors:  Doodipala Samba Reddy
Journal:  Expert Rev Neurother       Date:  2016-10-12       Impact factor: 4.618

Review 4.  Hormonal aspects of epilepsy.

Authors:  Page B Pennell
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.